Clinical trial
Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV). (CRUSTY + Trial)
NCT06044597 is registered in ClinicalTrials.gov with Antonio Rapacciuolo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV). (CRUSTY + Trial)
- Lead sponsor
- Antonio Rapacciuolo
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2023
- Completion date
- October 30, 2026
- Enrollment
- 722 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.